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Background Severe aortic stenosis (AS) is commonly associated with
mitral regurgitation (MR) in patients undergoing transcatheter aortic valve
replacement (TAVR). The natural history of MR is not well defined in this
population.
Methods Consecutive high risk, inoperable patients undergoing TAVR
between 2007 and 2011 for AS has echos at baseline and 1 year and were fol-
lowed for clinical outcomes. MR severity was graded and patients were
grouped as having minimal (none-mild) or significant (moderate- severe) MR.
Results 164 patients underwent TAVR, reducing gradients from 47 to
10mHg. LVEF increased from 48% to 52% while pulmonary aretry systolic
pressure (PAPS), LVESD and LVEDD were unchanged. Signficant MR pat-
ents had a median 1 grade reduction (p<0,0001) in MR at 1 year. Median
LVEF increased by 2% (p=0.0412). Median LVESD decreased by 2.3mm±7.5
(p=0.039). Univariate analysis showed no significant predictors of MR reduc-
tion in significant MR patients. Functional and organic significant MR
decreased after TAVR but only functional MR patients had improved LVEF
(6%, p=0.034), PAPS (5.9mmHg, p=0.022) and LVESD (3.8mm, p=0.013).
Multivariate analysis showed functional MR to be a predictor of improved
LVEF and PAPS. Clinical outcomes at a mean follow-up of 925 days were not
different in patients with significant vs minimal MR; however organic MR
patients tended to have more events than functional MR patients (p=0.06).
Conclusion: Significant MR patients undergoing TAVR for severe AS
improved in LVEF and LVESD, particularly patients with functional MR.
Organic MR is marginally predictive of cardiac complications in AS patients.
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Purpose Pilot study to evaluate the predictive value of repeated (admission
and 3 months) late gadolinium enhancement (LGE) on cardiac magnetic reso-
nance imaging (CMR) in acute viral myocarditis (AVM).
Method We prospectively included 49 patients hospitalized for an acute
viral myocarditis diagnosed by CMR according to Lake Louise Criteria. We
obtained written consent of all the patients. Patients were followed-up for one
year after the index admission for adverse cardiac events that included myo-
carditis recurrence, persistent chest pain, dyspnea or persistent/resurgent sign
of heart failure, documented sustained arrhythmias. Patients underwent a
second LGE-CMR 3 months after the index admission. LGE was analyzed
semi-quantitatively with the SQS score that has been validated in ischemic
cardiomyopathies.
Results The SQS calculated at the first CMR was poorly correlated with
cardiac necrosis biomarkers such as troponin peak (r2=0.22) or CPK
(r2=0.11), and inflammation biomarkers such as CRP (p=0,51). SQS1 was
also not predictive of adverse cardiac events after the index admission. How-
ever, the variation of SQS score between the first and second CMR showed
good pronostic value as estimated by ROC analysis (AUC, specificity 80%,
sensitivity 62%). This analysis also showed that patients with a decrease in
SQS<50% between the two CMR were at higher risk of adverse cardiac
events.
Conclusion The variation of LGE at admission of AVM and 3 months
afterwards appears as a promising tool to identify patients with high risk of
adverse envents during the year following a mild event of AVM.
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Background T2- and T1-mapping are novel CMR techniques allowing
tissue characterization. 
Aim To assess myocardial involvement using T2- and T1-mapping in
Tako-Tsubo cardiomyopathy (TC).
Methods 9 patients with TC and 15 controls were prospectively enrolled. 
Cardiovascular magnetic resonance (CMR) was performed a mean 2.8 days
after the onset of symptoms and after a mean 4.6 month follow-up. CMR was
applied using T2-mapping, pre and post contrast T1-mapping (MOLLI) and
late gadolinium enhancement (LGE) sequences. Segmental and global T1
values have been measured before and after contrast administration.
Results All patients were female, had positive troponin (6±9μg/l) and
medium and/or apical ballooning associated with moderate LV dysfunction
(EF 44±7%). On admission, compared with controls, TC patients had signifi-
cantly higher T2 values (65±6ms vs 50±4 ms, p<0.0001). Myocardial T2 was
significantly higher in segments with Wall motion abnormality (WMA) com-
pared to normokinetic segments (67±12ms vs 61.5±8 ms, p=0.003). Compared
with controls, TC patients had significantly higher pre contrast T1 values
(1115±92 versus 1016±89, p<0.0001) and significantly lower post contrast T1
values (428±24ms vs 466±19 ms, p=0.02).Pre contrast T1 values were signifi-
cantly higher in segments with WMA compared to normal segments (1126±95
vs 1089±85, p=0.016). 
Post contrast T1 values were not significantly different in abnormal seg-
ments compared to normal segments (421±56 vs 431±50, p=0.15). No patients
had LGE. At follow-up: all had a complete LV recovery (EF: 67±4%) without
significant WMA. Mean T2 and pre contrast T1 values decreased significantly
(53±6ms vs 65±8ms, p=0.001 and 1016±76 vs 1115±80, p=0.001 respec-
tively). No differences were observed regarding post contrast T1 values.
Conclusion In TC patients, T2-mapping and pre contrast T1-mapping
allow identification of reversible myocardial injury. Post contrast T1 mapping
does not provide additional information.
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Background Left atrial (LA) enlargement is associated with a poorer prog-
nosis in several diseases, including aortic stenosis (AS). However, apart dia-
stolic dysfunction, the main determinants of LA size in the setting of aortic
stenosis are poorly understood. 
Objective to assess the factors correlated with LA size in patients with
severe AS (aortic valve area (AVA) <1cm2 or <0.6cm2/m2) with preserved left
ventricular ejection fraction (LVEF >50%). 
Methods 80 consecutive patients with isolated severe AS in sinus rhythm
(mean age 72±10 years, AVA 0.8±0.2cm2, 0.44±0.1cm2/m2, mean gradient
45±15mmHg, LVEF 68±10%) underwent a comprehensive transthoracic
